A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing | Zendy

Stephen E. Kimmel | Zendy; Benjamin French | Zendy; Scott E. Kasner | Zendy; Julie A. Johnson | Zendy; Jeffrey L. Anderson | Zendy; Brian F. Gage | Zendy; Yves Rosenberg | Zendy; Charles S. Eby | Zendy; Rosemary Madigan | Zendy; Robert D. McBane | Zendy; Sherif Z. AbdelRahman | Zendy; Scott M. Stevens | Zendy; Steven H. Yale | Zendy; Emile R. Mohler | Zendy; Margaret C. Fang | Zendy; Vinay Shah | Zendy; Richard B. Horenstein | Zendy; Nita A. Limdi | Zendy; James A.S. Muldowney | Zendy; Jaspal Gujral | Zendy; Patrice Delafontaine | Zendy; Robert J. Desnick | Zendy; Thomas L. Ortel | Zendy; Henny H. Billett | Zendy; Robert C. Pendleton | Zendy; Nancy L. Geller | Zendy; Jonathan L. Halperin | Zendy; Samuel Z. Goldhaber | Zendy; Michael D. Caldwell | Zendy; Robert M. Califf | Zendy; Jonas H. Ellenberg | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

A Pharmacogenetic versus a Clinical Algorithm for Warfarin Dosing

Author(s) -

Stephen E. Kimmel,

Benjamin French,

Scott E. Kasner,

Julie A. Johnson,

Jeffrey L. Anderson,

Brian F. Gage,

Yves Rosenberg,

Charles S. Eby,

Rosemary Madigan,

Robert D. McBane,

Sherif Z. AbdelRahman,

Scott M. Stevens,

Steven H. Yale,

Emile R. Mohler,

Margaret C. Fang,

Vinay Shah,

Richard B. Horenstein,

Nita A. Limdi,

James A.S. Muldowney,

Jaspal Gujral,

Patrice Delafontaine,

Robert J. Desnick,

Thomas L. Ortel,

Henny H. Billett,

Robert C. Pendleton,

Nancy L. Geller,

Jonathan L. Halperin,

Samuel Z. Goldhaber,

Michael D. Caldwell,

Robert M. Califf,

Jonas H. Ellenberg

Publication year - 2013

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 19.889

H-Index - 1030

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa1310669

Subject(s) - medicine , dosing , pharmacogenetics , warfarin , medline , intensive care medicine , pharmacology , genotype , atrial fibrillation , gene , biochemistry , chemistry , political science , law

The clinical utility of genotype-guided (pharmacogenetically based) dosing of warfarin has been tested only in small clinical trials or observational studies, with equivocal results.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research